Artrya LimitedASX: AYA

Artrya September Quarter - Report Timing & Investor Webinar

· Issued by Artrya Limited via ASX

Filed with ASX · · 1 page · English

Summary by 6ix AI

Artrya Limited has announced the timing for its September quarterly report and an upcoming investor webinar. The quarterly activities and cashflow report will be released on a specified date, followed by a webinar hosted by the CEO and CFO. During the webinar, they will discuss the company's activities, results, and business outlook, with a Q&A session for shareholders. Artrya is focused on developing AI-powered solutions for the detection and management of coronary artery disease.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/artrya-september-quarter-report-timing-and-investor-webinar

Release

Coronary Artery Disease. We see you. September 2026 Quarterly Report - Timing & Investor Webinar Investor Call 11am AEDT (8am AWST), Monday 26 October 2026 PERTH, Australia, 22 October 2026: Artrya Limited (ASX: AYA) (Artrya or the Company), a medical technology ® company commercialising its Salix...

Artrya Limited on 6ix

Earlier from Artrya

Later from Artrya

All Artrya news releases